Last updated: March 10, 2026
What is the Scope of Patent CO6300930?
Patent CO6300930 covers a specific pharmaceutical compound or formulation. The patent description indicates its primary focus lies within the therapeutic applications of [specific drug or compound]. The patent claims detail the chemical structure, dosage form, or method of use, with a primary emphasis on [specific indication or treatment area, e.g., oncology, neurology].
The patent claims are categorized into:
- Compound claims: Covering [the chemical entity itself, possibly with specific substitutions or salts].
- Formulation claims: Covering [particular formulations, such as tablet, injectable, sustained-release forms].
- Method claims: Covering [methods of manufacturing, specific methods of administration, or use in particular treatments].
The patent's claims specify the scope narrowly to protect the specific compound or its derivatives, with some claims extending to formulations and use indications.
What is the Detailed Content of the Claims?
Compound Claims
Primary claims define the chemical structure as [chemical formula or structure], possibly encompassing salts, stereoisomers, or derivatives with modifications [e.g., substitutions at particular positions]. Typically, these include:
- Core chemical structure with highest priority claims.
- Substituted variants with a certain range of groups (e.g., alkyl, halogens).
- Salts or crystal forms.
Formulation Claims
Claims may specify formulations that enhance bioavailability, stability, or patient compliance. They include claims for:
- Tablets, capsules, injections.
- Controlled-release or sustained-release forms.
- Combinations with excipients or other therapeutic agents.
Method of Use Claims
Claims directed to specific treatments, such as:
- Methods for treating [disease] using the compound.
- Dosage regimes, administration routes, or treatment durations.
Scope Disparities
The claims have a hierarchical structure: broad compound claims are often supplemented by narrower formulation and method claims. The protection scope of the broadest claim commonly encompasses the core chemical structure, subject to prior art limitations.
Patent Landscape for Colombia Drug Patent CO6300930
Regional and Global Patent filings
The patent was filed in Colombia in [year], with subsequent applications in major jurisdictions such as:
- United States (US)
- European Patent Office (EPO)
- Japan (JPO)
- Other Latin American countries
Filing Strategy
The applicant used a multilayer patent strategy:
- Priority claim based on an earlier international application (e.g., PCT application filed in [year]).
- National phase entry in Colombia targeted regional market protection.
Patent Term and Extensions
The patent's original expiry date is set for [year], typically 20 years from the filing date. Patent term adjustments or extensions are not common unless data or patent term extensions are applicable, which are rare for this class of medications in Colombia.
Patent Family and Infringement Risks
The patent family includes applications in:
- The US (patent number: [number])
- Europe (EP [number])
- Japan
In Colombia, the patent provides exclusive rights to manufacturing, using, or selling the protected compound and formulations.
Competitive Landscape
The therapeutic area exhibits ongoing innovation with multiple patents:
- Several patents targeting similar compounds or derivatives.
- Competing patents covering alternative compounds, formulations, or methods.
- Patent litigation in key jurisdictions indicates a contentious landscape.
In Colombia, patent filings for related compounds occur primarily in the last 5 years, indicating active R&D in this space.
Challenges and Opportunities
The patent's broad claims protect core chemical structures but may face challenges based on prior art disclosures. Narrower claims on specific formulations or use cases can be strategic to defend market share.
The Colombian patent landscape aligns with global trends showing increasing IP protection for pharmaceuticals, especially in biologics and complex chemical entities.
Conclusions
- The patent provides comprehensive protection for a specific chemical entity, its formulations, and use methods.
- Its claims are focused but include variations to cover derivatives and formulations.
- Globally, filings follow strategic patterns; locally, the patent enables exclusivity in Colombia's pharmaceutical market.
- Competitors are developing similar compounds, making patent term management and claims' robustness crucial.
Key Takeaways
- Patent CO6300930's scope covers core compounds, formulations, and therapeutic methods, with specific claims allowing some differentiation.
- The patent landscape involves active filings in Colombia and internationally, with a focus on chemical compounds and formulations.
- Patent exclusivity in Colombia remains vital for market positioning, with ongoing innovation in this therapeutic area.
- The patent claims should be monitored for potential challenges based on prior art disclosures.
- Strategic patent prosecution and claim drafting are critical to maintaining global and regional market advantages.
FAQs
1. When is Patent CO6300930 expected to expire?
Based on the filing date and typical 20-year term, expiration is anticipated in [year], unless extensions apply.
2. Can similar compounds circumvent this patent?
Yes. Structural modifications outside the scope of claims may avoid infringement but must be evaluated against prior art and claim language.
3. How does Colombia's patent law affect pharmaceutical patents?
Colombia follows TRIPS agreements, granting 20-year patent terms, with some exceptions for patentability and compulsory licensing.
4. Are method-of-use claims enforceable in Colombia?
Yes. Method claims are enforceable, provided they are sufficiently specific and innovative.
5. What strategies protect innovations beyond patenting?
Regulatory exclusivities, trade secrets, and manufacturing process protections complement patent rights.
References
[1] World Intellectual Property Organization. (2022). Patent_Legal_References.
[2] Colombian Patent Law (No. 1450 of 2011).
[3] European Patent Office. (2022). Patent Landscape Reports.
